Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;21(1):57-61.
doi: 10.22074/cellj.2019.5750. Epub 2018 Nov 18.

Induction Effects of Bacteroides fragilis Derived Outer Membrane Vesicles on Toll Like Receptor 2, Toll Like Receptor 4 Genes Expression and Cytokines Concentration in Human Intestinal Epithelial Cells

Affiliations

Induction Effects of Bacteroides fragilis Derived Outer Membrane Vesicles on Toll Like Receptor 2, Toll Like Receptor 4 Genes Expression and Cytokines Concentration in Human Intestinal Epithelial Cells

Sara Ahmadi Badi et al. Cell J. 2019 Apr.

Abstract

Objective: Gastrointestinal (GI) tract, like other mucosal surface, is colonized with a microbial population known as gut microbiota. Outer membrane vesicles (OMVs) which are produced by gram negative bacteria could be sensed by Toll like receptors (TLRs). The interaction between gut microbiota and TLRs affects homeostasis and immune responses. In this study, we evaluated TLR2, TLR4 genes expression and cytokines concentration in Caco-2 cell line treated with Bacteroides fragilis (B. fragilis) and its OMVs.

Materials and methods: In this experimental study, OMVs were extracted using sequential centrifugation and their physicochemical properties were evaluated as part of quality control assessment. Caco-2 cells were treated with B. fragilis and its OMVs (180 and 350 μg/ml). Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was performed to assess TLR2 and TLR4 mRNA expression levels. Pro-inflammatory (IFNᵧ) and anti-inflammatory (IL- 4 and IL-10) cytokines were evaluated by ELISA.

Results: B. fragilis significantly decreased TLR2 and slightly increased TLR4 mRNA levels in Caco-2 cell line. The TLR2 mRNA level was slightly increased at 180 and 350 μg/ml of OMVs. Conversely, the TLR4 mRNA level was decreased at 180 μg/ml of OMVs, while it was significantly increased at 350 μg/ml of OMVs. Furthermore, B. fragilis and its OMVs significantly increased and decreased IFNᵧ concentration, respectively. Anti-inflammatory cytokines were increased by B. fragilis and its OMVs.

Conclusion: B. fragilis and its OMVs have pivotal role in the cross talk between gut microbiota and the host especially in the modulation of the immune system. Based on the last studies on immunomodulatory effect of B. fragilis derived OMVs on immune cells and our results, we postulate that B. fragilis derived OMVs could be possible candidates for the reduction of immune responses.

Keywords: Bacteroides fragilis; Gut Microbiota; Membrane Vesicles; Toll Like Receptors.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest in this study.

Figures

Fig.1
Fig.1
B. fragilis produces outer membrane vesicles (OMVs) with a mean dimention of 85.7 ± 15.3 nm: scanning electron microscopy of B. fragilis derived-OMVs (magnification: ×20K).
Fig.2
Fig.2
Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analyzes of B. fragilis and its outer membrane vesicles (OMVs) on TLR genes expressions. A. The cells were initially deprived of serum and then treated with either B. fragilis or phosphate buffer solution (PBS) overnight and B. In the same condition, the other group cells were treated with either B. fragilis derived OMVs (350 and 180 µg/ml) or sucrose, overnight. Values of triplicate experiments are demonstrated as mean ± SD. Significant results are presented as ** based on P<0.01.
Fig.3
Fig.3
ELISA analyzes of B. fragilis and its outer membrane vesicles (OMVs) on cytokines concentration. A. Cells were initially deprived of serum and then treated with either B. fragilis or phosphate buffer solution (PBS), overnight and B. In the same condition, the other group cells were treated with either B. fragilis derived OMVs (350 and 180 µg/ml) or sucros, for overnight. Values of triplicate experiments are demonstrated as mean ± SD. Significant results are presented as *, **, ***, **** based on P<0.05, P<0.01, P<0.001, and P<0.0001.

References

    1. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859–904. - PubMed
    1. Ho JT, Chan GC, Li JC. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol. 2015;16:21–21. - PMC - PubMed
    1. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323. - PMC - PubMed
    1. Muraca M, Putignani L, Fierabracci A, Teti A, Perilongo G. Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease. Discov Med. 2015;19(106):343–348. - PubMed
    1. König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, et al. Human intestinal barrier function in Health and Disease. Clin Transl Gastroenterol. 2016;7(10):e196–e196. - PMC - PubMed

LinkOut - more resources